Moderna, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $108.4m
$205.8m +89.88%
$135.1m -34.38%
$60.2m -55.42%
$803.4m +1234.34%
$18.5b +2199.12%
$19.3b +4.29%
$6.8b -64.45%
$3.2b -52.75%
$1.9b -39.93%
Cost of Revenue $274.7m
$410.5m +49.41%
$0 -100.00%
$0 $7.9m
$2.6b +32888.78%
$5.4b +106.95%
$4.7b -13.35%
$1.5b -68.80%
$868.0m -40.71%
Cost of sales $274.7m
$410.5m +49.41%
$0 -100.00%
$0 $7.9m
$2.6b +32888.78%
$5.4b +106.95%
$4.7b -13.35%
$1.5b -68.80%
$868.0m -40.71%
Gross Profit (Calculated) (derived) ($166.3m)
($204.6m) -23.04%
$135.1m +166.00%
$60.2m -55.42%
$795.5m +1221.17%
$15.9b +1893.06%
$13.8b -12.66%
$2.2b -84.44%
$1.8b -17.77%
$1.1b -39.28%
Research and Development Expense $274.7m $410.5m $454.1m $496.3m $1.4b $2.0b $3.3b $4.8b $4.5b $3.1b
General and Administrative Expense $57.5m $64.7m $94.3m $109.6m $188.3m $567.0m $1.1b $1.5b $1.2b $1.0b
Operating Expenses $332.2m $475.2m $548.3m $605.9m $1.6b $5.2b $9.8b $11.1b $7.2b $5.0b
Loss from operations ($223.8m)
($269.4m) -20.37%
($413.3m) -53.43%
($545.7m) -32.05%
($763.1m) -39.84%
$13.3b +1842.27%
$9.4b -29.15%
($4.2b) -145.00%
($3.9b) +6.94%
($3.1b) +22.08%
Operating Income (Loss) ($223.8m)
($269.4m) -20.37%
($413.3m) -53.43%
($545.7m) -32.05%
($763.1m) -39.84%
$13.3b +1842.27%
$9.4b -29.15%
($4.2b) -145.00%
($3.9b) +6.94%
($3.1b) +22.08%
Interest income $11.3m $15.2m $27.0m $38.5m $24.7m $18.0m $200.0m $421.0m $425.0m $314.0m
Equity Securities, FV-NI, Realized Gain (Loss) ($35.0m) ($52.0m) ($8.0m)
Other Nonoperating Income (Expense) ($2.7m) ($1.9m) $1.8m ($7.5m) ($6.1m) ($29.0m) ($45.0m) ($124.0m) ($87.0m) ($8.0m)
Other expense, net ($2.7m) ($1.9m) $1.8m ($7.5m) ($6.1m) ($29.0m) ($45.0m) ($124.0m) ($87.0m) ($8.0m)
Income (Loss) from Continuing Operations before Income Taxes, Domestic ($247.8m) ($380.5m) ($508.6m) ($745.4m) $13.1b $9.4b ($4.1b) ($3.7b) ($2.7b)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest ($515.0m) ($744.0m) $13.3b $9.6b ($3.9b) ($3.6b) ($2.8b)
Current Income Tax Expense (Benefit) ($80k) $326k $505k $2.6m $1.4b $1.8b ($129.0m) ($45.0m) $44.0m
Income Tax Expense (Benefit) $1.0m ($80k) $326k ($695k) $2.6m $1.1b $1.2b $772.0m ($46.0m) $54.0m
Net loss ($216.2m) ($255.9m) ($384.7m) ($514.0m) ($747.1m) $12.2b $8.4b ($4.7b) ($3.6b) ($2.8b)
Net Income (Loss) Attributable to Parent ($216.2m)
($255.9m) -18.36%
($384.7m) -50.34%
($514.0m) -33.60%
($747.1m) -45.34%
$12.2b +1733.33%
$8.4b -31.47%
($4.7b) -156.37%
($3.6b) +24.46%
($2.8b) +20.75%
Net Income (Loss) Available to Common Stockholders, Basic ($269.8m)
($401.9m) -48.92%
($514.0m) -27.91%
($747.1m) -45.34%
Earnings Per Share, Basic ($1.96) $30.31 $21.26 ($12.33) ($9.28) ($7.26)
Earnings Per Share, Diluted $28.29 $20.12 ($12.33) ($9.28) ($7.26)
Weighted Average Number of Shares Outstanding, Basic 331.0m 381.0m 403.0m 394.0m 382.0m 384.0m 389.0m
Basic (in shares) $331.0m $381.0m $403.0m $394.0m $382.0m $384.0m $389.0m
Diluted (in shares) $331.0m $381.0m $431.0m $416.0m $382.0m $384.0m $389.0m
Weighted Average Number of Shares Outstanding, Diluted 331.0m 381.0m 431.0m 416.0m 382.0m 384.0m 389.0m
Additional Financial Items
Costs and Expenses $332.2m $475.2m $548.3m $605.9m $1.6b $5.2b $9.8b $11.1b $7.2b $5.0b
Provision for (benefit from) tax provision $1.0m ($80k) $326k ($695k) $2.6m $1.1b $1.2b $772.0m ($46.0m) $54.0m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.